Free Trial

LungLife AI (LLAI) Competitors

GBX 2.40 +0.15 (+6.67%)
As of 05:20 AM Eastern

LLAI vs. DMTR, LLA, IDHC, DXRX, AGL, YGEN, ABDX, PRM, GDR, and VRCI

Should you be buying LungLife AI stock or one of its competitors? The main competitors of LungLife AI include Deepmatter Group (DMTR), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), and Verici Dx (VRCI). These companies are all part of the "diagnostics & research" industry.

LungLife AI vs.

LungLife AI (LON:LLAI) and Deepmatter Group (LON:DMTR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Deepmatter Group received 54 more outperform votes than LungLife AI when rated by MarketBeat users.

CompanyUnderperformOutperform
LungLife AIN/AN/A
Deepmatter GroupOutperform Votes
54
62.79%
Underperform Votes
32
37.21%

42.5% of LungLife AI shares are held by institutional investors. 48.4% of LungLife AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Deepmatter Group has higher revenue and earnings than LungLife AI. LungLife AI is trading at a lower price-to-earnings ratio than Deepmatter Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LungLife AI£33.87K23.48-£5.22M-£12.58-0.19
Deepmatter Group£1.04M0.00N/A-£0.30N/A

Deepmatter Group has a net margin of 0.00% compared to LungLife AI's net margin of -15,403.45%. Deepmatter Group's return on equity of 0.00% beat LungLife AI's return on equity.

Company Net Margins Return on Equity Return on Assets
LungLife AI-15,403.45% -56.38% -27.28%
Deepmatter Group N/A N/A N/A

In the previous week, LungLife AI's average media sentiment score of 0.00 equaled Deepmatter Group'saverage media sentiment score.

Company Overall Sentiment
LungLife AI Neutral
Deepmatter Group Neutral

Summary

Deepmatter Group beats LungLife AI on 7 of the 9 factors compared between the two stocks.

Get LungLife AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for LLAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LLAI vs. The Competition

MetricLungLife AIDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£795,000.00£788.77M£5.56B£2.56B
Dividend YieldN/A5.44%5.11%4.97%
P/E Ratio-0.191.9822.48132.78
Price / Sales23.48409.03394.56244,461.27
Price / Cash2.2811.4238.1828.13
Price / Book0.092.776.774.55
Net Income-£5.22M£308.37B£3.22B£5.84B
7 Day Performance17.02%-1.13%1.48%2.92%
1 Month Performance140.00%-3.91%3.99%8.98%
1 Year Performance-91.11%-7.17%16.15%114.84%

LungLife AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LLAI
LungLife AI
N/AGBX 2.40
+6.7%
N/A-91.1%£795,000.00£33,871.03-0.1915Gap Up
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-8.3315Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
flat
N/A+16.7%£10.60B£23.29T13.386,692Gap Down
DXRX
Diaceutics
2.8502 of 5 stars
GBX 118.50
flat
GBX 160
+35.0%
+21.2%£100.01M£26.08M-35.15151News Coverage
AGL
ANGLE
1.6365 of 5 stars
GBX 9.18
+2.0%
GBX 40
+335.7%
-36.0%£29.58M£2.44M-1.36650Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 6
flat
N/A-43.6%£11.62M£3.84M-14.5984Positive News
Gap Up
PRM
Proteome Sciences
N/AGBX 3.18
+1.0%
N/A-23.1%£9.39M£10.88B-2.30240Gap Down
GDR
genedrive
N/AGBX 1.51
-0.3%
N/A-70.1%£8.55M£1.50M-0.4243High Trading Volume
VRCI
Verici Dx
N/AGBX 1.79
-4.8%
N/A-79.4%£5.42M£5.91M-1.0319Gap Down

Related Companies and Tools


This page (LON:LLAI) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners